Sodium Sulfacetamide NDC 58657-477

NDC codes

FDA NDC Directory

Product NDC (as listed)58657-477Labeler and product segments. Claims need a package NDC.

Product NDC at billing width58657-0477Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
58657-477-06	58657047706	177 g in 1 BOTTLE (58657-477-06)Marketed from Jan 15, 2022
58657-477-12	58657047712	355 g in 1 BOTTLE (58657-477-12)Marketed from Jan 15, 2022
58657-477-16	58657047716	480 g in 1 BOTTLE (58657-477-16)Marketed from Jan 15, 2022

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Sodium Sulfacetamide
Generic name (nonproprietary): sodium sulfacetamide
Active ingredients: Sulfacetamide sodium — 100 mg/g
Dosage form: Liquid
Route: Topical
Labeler: Method Pharmaceuticals, LLC
Product type: Prescription drug
Marketing category: Unapproved drug (other)
Marketing start: Jan 15, 2022
Listing expires: Dec 31, 2027
Other FDA classes: Sulfonamides (Chemical structure)
Identifiers: Product ID 58657-477_4aad445c-77e0-b8cd-e063-6394a90afd06SPL ID 4aad445c-77e0-b8cd-e063-6394a90afd06SPL set ID d65e777b-682b-732d-e053-2a95a90a41adRxCUI 1006107UNII 4NRT660KJQ
Pharmacologic class: Sulfonamide Antibacterial

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N458657047706 followed by a unit qualifier and the quantity

Package 58657-0477-06. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Feb 12, 2026.

Indications (excerpt from the label)

Indications This product is intended for topical application in the following scaling dermatoses: seborrheic dermatitis and seborrhea sicca (dandruff). It also is indicated for the treatment of secondary bacterial infections of the skin due to organisms susceptible to sulfonamides.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)